Liminal BioSciences Inc LMNL:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
4.15quote price arrow down-0.05 (-1.19%)
Volume
1,700
Close
4.20quote price arrow up+0.19 (+4.74%)
Volume
429,383
52 week range
3.51 - 31.45

...

Loading . . .

KEY STATS

  • Open4.05
  • Day High4.22
  • Day Low3.70
  • Prev Close4.01
  • 52 Week High31.45
  • 52 Week High Date07/01/20
  • 52 Week Low3.51
  • 52 Week Low Date11/13/20
  • Market Cap123.44M
  • Shares Out29.39M
  • 10 Day Average Volume0.59M
  • Dividend-
  • Dividend Yield-
  • Beta1.74
  • 1 Year % Change-54

RATIOS/PROFITABILITY

  • EPS (TTM)18.97
  • P/E (TTM)0.22
  • Fwd P/E (NTM)-1.27
  • EBITDA (MRQ)-76.85M
  • ROE (MRQ)-156.97%
  • Revenue (MRQ)2.63M
  • Gross Margin (MRQ)36.49%
  • Net Margin (MRQ)-3,550.96%
  • Debt To Equity (MRQ)209.63%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Liminal BioSciences Inc News

There is no recent news for this security.

Latest LMNL News From Our Partners

QUOTE FINDER

Profile

MORE
Liminal BioSciences Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing treatments for patients suffering from diseases primarily related to fibrosis, including respiratory, liver and kidney diseases. The Company operates through two segments: Small Molecule Therapeutics Segment and Plasma-derived Therapeutics Segment. The Small Molecule Therapeutics Segment is a small-molecule drug development...
Aleksander Krstajic
Non-Executive Chairman
Kenneth Galbraith
Chief Executive Officer
Patrick Sartore
Chief Operating Officer
Bruce Pritchard
Chief Operating Officer
Murielle Lortie CPA
Chief Financial Officer
Marie Iskra
General Counsel
Address
440 BOULEVARD ARMAND, FRAPPIER #300
Laval, QC
H7V 4B4
Canada